Oral use of biotin in seborrhoeic dermatitis of infancy: a controlled trial.
A double-blind cross-over trial of biotin given by mouth in the treatment of seborrhoeic dermatitis of infancy did not show a statistically significant advantage of biotin over placebo.
D001710:Biotin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D006801:Humans; D007223:Infant
D001710:Biotin